c-myc gene expression in human cells is controlled by glucose.
The c-myc oncogene is implicated in normal growth and differentiation processes. Human cell lines IM9 and HepG2 stably cultured at "low" glucose concentrations (5.5 mM) show c-myc mRNA levels 3-4 times higher than cells cultured at "high" glucose concentrations (25 nM). D-fructose (a metabolizable exose) substitutes for D-glucose in reducing c-myc expression while 3-ortho-methylglucose (a non metabolizable exose) is uneffective. c-myc expression is up-regulated (by PMA) or down-regulated (by dexamethasone and long-term exposure to FCS) in human cells cultured at "low" glucose but not in cells cultured at "high" glucose. We previously demonstrated that insulin receptor gene expression in human cell lines in enhanced by glucose. Therefore, glucose controls in an opposite way the expression of two genes important in the regulation of eukaryotic cell growth and differentiation.
Briata
P
P
Laboratory of Immunobiology, National Cancer Institute I.S.T. Genova, Italy.
Laurino
C
C
Gherzi
R
R
D019325:3-O-Methylglucose; D000818:Animals; D006528:Carcinoma, Hepatocellular; D002417:Cattle; D003907:Dexamethasone / Q000494:pharmacology; D005312:Fetal Blood; D005632:Fructose / Q000494:pharmacology; D005786:Gene Expression Regulation / Q000187:drug effects*; D005947:Glucose / Q000008:administration & dosage / Q000494:pharmacology*; D006801:Humans; D008113:Liver Neoplasms; D008214:Lymphocytes; D008757:Methylglucosides / Q000494:pharmacology; D011518:Proto-Oncogene Proteins / Q000235:genetics*; D016271:Proto-Oncogene Proteins c-myc; D011519:Proto-Oncogenes; D012333:RNA, Messenger / Q000096:biosynthesis; D013755:Tetradecanoylphorbol Acetate / Q000494:pharmacology; D014407:Tumor Cells, Cultured
D008757:Methylglucosides; D011518:Proto-Oncogene Proteins; D016271:Proto-Oncogene Proteins c-myc; D012333:RNA, Messenger; D019325:3-O-Methylglucose; D005632:Fructose; D003907:Dexamethasone; D005947:Glucose; D013755:Tetradecanoylphorbol Acetate